Richard Pazdur

Last updated
Printz, Carrie (June 2021). "First person profile: Richard Pazdur, MD: The founding director of the FDA's Oncology Center of Excellence has long spearheaded major initiatives to improve oncology drug development". Cancer. 127 (11): 1731–1733. doi: 10.1002/cncr.33631 . PMID   33970487. S2CID   234346640.
  • ↑ Commissioner, Office of the (23 April 2019). "Richard Pazdur". U.S. Food and Drug Administration. Archived from the original on September 12, 2019.
  • ↑ "FDA officially launches its Oncology Center of Excellence (OCE)". WEP Clinical. 31 January 2017. Retrieved 23 May 2022.
  • ↑ "FDA taps oncology expert Pazdur as nation's top drug regulator". Washington Post. 11 November 2025. Retrieved 11 November 2025.
  • ↑ Hagen, Tony (30 December 2019). "Pazdur Followed the Pathway of Greatest Resistance to the FDA". OncologyLive.
    • Richard Pazdur
    Director of Center for Drug Evaluation and Research
    Incumbent
    Assumed office
    2025
    Authority control databases: Academics OOjs UI icon edit-ltr-progressive.svg
    This page is based on this Wikipedia article
    Text is available under the CC BY-SA 4.0 license; additional terms may apply.
    Images, videos and audio are available under their respective licenses.